Displaying items by tag: division of preventive medicine

Studies by the team led by Stefan G. Kertesz, M.D., have shown that homeless patients often feel unwelcome or rejected when seeking health care.
Many patients have been struggling to pay for their treatment, and the financial consequences can affect a person’s emotional well-being. This collaborative effort will recruit researchers nationwide to help solve these issues.
UAB researchers examined the lack of representation of women and racial/ethnic minorities in higher levels of academic medicine and created several initiatives to ensure that, moving forward, UAB is part of the solution.
Research found that gaining community members’ perspectives to identify barriers and facilitators to COVID-19, related to prevention, coping and testing, may potentially improve outcomes.
This specialized office at the O’Neal Cancer Center marks its silver anniversary with renewed commitment to reaching the medically underserved and tackling cancer health disparities in the state and surrounding areas.
As the country has grappled with an opioid crisis and with COVID-19, a third crisis has brewed. Suicide is now the 10th leading cause of death in the United States.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
Cancer centers nationwide, including the O’Neal Comprehensive Cancer Center at UAB as a leading site, are joining together to address the impact of COVID-19 pandemic on cancer prevention and treatment.
Drs. Vickers and Pisu will use a $3 million, five-year National Institute on Minority Health and Health Disparities grant to study barriers that may exist for GI cancer patients to access quality cancer surgery in Alabama and Mississippi.
Three UAB doctors and professors share five ways the medical community can work to address the needs of underrepresented populations as we work to understand COVID-19.
Delays in cancer screenings due to the coronavirus could lead to thousands of cancer deaths in the coming years. O’Neal Comprehensive Cancer Center at UAB is vigilant in its efforts to provide uninterrupted care to patients.
Dual antiplatelet therapy after percutaneous coronary intervention uses aspirin and one other drug, among several choices. But which drug is best to use?
Page 3 of 9